Compatibility of Apheresis Platelet Collections with Pathogen Reduction While Maintaining Current Split Rates

被引：0
|
作者：
Weiner, Elan [1 ]
Chrebtow, Vera [1 ]
机构：
[1] Cerus Corp, Concord, CA USA
来源：
TRANSFUSION | 2017年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C43-A03F
引用
收藏
页码：40A / 41A
页数：2
相关论文
共 29 条
  • [1] How do we implement pathogen reduction technology, while maintaining an adequate platelet inventory for our patients?
    Nguyen, Jennifer T.
    Rioveros, Jowin
    Ziman, Alyssa
    McGonigle, Andrea
    Ward, Dawn C.
    [J]. TRANSFUSION, 2021, 61 (04) : 1014 - 1022
  • [2] The effects of pathogen reduction technology on apheresis platelet concentrates stored in Pas
    Tsalas, Stavros
    Tsantes, Andreas G.
    Petrou, Eleni
    Mellou, Sofia
    Sokou, Rozeta
    Loukopoulou, Electra
    Kriebardis, Anastasios G. .
    Fortis, Sotirios P.
    Papadopoulos, Dimitrios V.
    Vaiopoulos, Aristeidis G.
    Kokoris, Styliani
    Tsantes, Argirios E.
    [J]. BLOOD TRANSFUSION, 2024, 22 (05)
  • [3] IN VITRO APHERESIS PLATELET FUNCTION UNDER ADDITIVE SOLUTION AND PATHOGEN REDUCTION STRATEGIES
    Ekaney, Michael
    Bartl, Neal
    Evans, Susan
    [J]. CRITICAL CARE MEDICINE, 2024, 52
  • [4] Combining Apheresis and Pathogen Reduction Standardizes Platelet Products and Enhances Blood Safety
    Sevcik, H.
    Hoecker, P.
    [J]. TRANSFUSION, 2012, 52 : 71A - 71A
  • [5] Implementation strategy for complete pathogen reduction technology treated apheresis platelet inventory
    Shu, Elaine
    Batilo, Concepcion Dela Cruz
    Sussmann, Harry
    Owen, Bethany
    Belanger, Geoffrey A.
    Pandey, Suchitra
    Pham, Tho D.
    [J]. TRANSFUSION, 2022, 62 (10) : 2108 - 2116
  • [6] Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies
    Picker, Susanne M.
    Schneider, Volker
    Gathof, Birgit S.
    [J]. TRANSFUSION, 2009, 49 (06) : 1224 - 1232
  • [7] Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products
    Li, J
    de Korte, D
    Woolum, MD
    Ruane, PH
    Keil, SD
    Lockerbie, O
    McLean, R
    Goodrich, RP
    [J]. VOX SANGUINIS, 2004, 87 (02) : 82 - 90
  • [8] Optimization of the Apheresis Collection Process: Improving the Platelet Supply Capability While Maintaining the Same Donor Population
    Cayer, Marie-Pierre
    Ducas, Eric
    de Grandmont, Marie Joelle
    Dussault, Nathalie
    Sauvageau, Synthia
    Rabusseau, Isabelle
    Levesque, Luc
    Jacques, Annie
    Brouard, Danny
    [J]. TRANSFUSION, 2017, 57 : 237A - 237A
  • [9] Increasing the Platelet Count Upper Limit Reduced the Number of Apheresis Platelet Discards With the Pathogen-Reduction Process
    Carlson, Jacqueline
    Hammel, Scott A.
    Gandhi, Manish J.
    Stubbs, James R.
    [J]. TRANSFUSION, 2019, 59 : 60A - 61A
  • [10] Impact of a transfusion-related acute lung injury reduction strategy on apheresis platelet collections
    Williams, Dennis
    Rao, Marepalli
    Carey, Patricia
    [J]. JOURNAL OF CLINICAL APHERESIS, 2012, 27 (04) : 205 - 211
123